Cargando…
Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India
Data supporting use of concurrent chemoradiation in locally advanced lung cancers comes from clinical trials from developed countries. Applicability and outcomes of such schedules in developing countries is not widely reported. There are various challenges in delivering chemoradiation in locally adv...
Autor principal: | Agrawal, Sushma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889058/ https://www.ncbi.nlm.nih.gov/pubmed/24455655 http://dx.doi.org/10.4103/2278-330X.119893 |
Ejemplares similares
-
Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer
por: Hassanzadeh, Comron, et al.
Publicado: (2020) -
Effects of β-Adrenergic Antagonists on Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
por: Chaudhary, Kunal R., et al.
Publicado: (2019) -
Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer
por: Takigawa, N, et al.
Publicado: (2006) -
A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancer
por: Prasad, Rahul N., et al.
Publicado: (2020) -
Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
por: Schreiner, Waldemar, et al.
Publicado: (2016)